Mechanistically, the under‐expression of ZFP14 was attributed to the impaired m6A modification involving a novel collaboration between METTL14 and IGF2BP2 specific to ccRCC. The gene discussed is METTL14; the disease is nonpapillary renal cell carcinoma.